UBE Corp
XMUN:UBE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
UBE Corp
XMUN:UBE
|
JP |
|
S
|
Societe BIC SA
OTC:BICEF
|
FR |
|
M
|
Mega Lifesciences PCL
SET:MEGA
|
TH |
|
M
|
Mitsui Chemicals Inc
XMUN:MSI
|
JP |
|
A
|
Abeona Therapeutics Inc
F:PCJP
|
US |
|
S
|
Shin-Etsu Chemical Co Ltd
XMUN:SEH
|
JP |
|
M&G PLC
F:7MP
|
UK |
|
H
|
Hanover Insurance Group Inc
XBER:AF4
|
US |
Wall St Price Targets
UBE Price Targets Summary
UBE Corp
According to Wall Street analysts, the average 1-year price target for UBE is 16.02 EUR with a low forecast of 13.12 EUR and a high forecast of 20.47 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UBE's stock price target?
Price Target
16.02
EUR
According to Wall Street analysts, the average 1-year price target for UBE is 16.02 EUR with a low forecast of 13.12 EUR and a high forecast of 20.47 EUR.
What is the Revenue forecast for UBE Corp?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 3 years is 0%.
What is the Operating Income forecast for UBE Corp?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been -7%. The projected CAGR for the next 10 years is 4%.
